Samantha Ramachandra
Research Subjects
Samantha Ramachandra has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ekta Gupta
University Aberdeen
1 shared publication - H. M. R. W. Angammana
Department of Basic Sciences Faculty of Dental Sciences University of Peradeniya Sri Lanka
1 shared publication - J. A. P Jayasinghe
Institute of Dentistry, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
1 shared publication - Manjula Manoji Weerasekera
Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Colombo, Sri Lanka
1 shared publication - Nadisha Sewwandi Piyarathne
Institute of Dentistry University of Aberdeen Aberdeen UK
1 shared publication - Peter Langhorne
University of Glasgow
1 shared publication
Latest Publications
- Open Access
- 12 July 2021
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 21 (8) , 789-807
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review
Introduction: Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) are a significant health burden globally. Smoking, alcohol and betel quid are the main risk factors. Lack of screening methods has been highlighted as a significant challenge in management. Salivary biomarkers are proposed as non-invasive diagnostic tools. The aim of this systematic review was to study salivary biomarkers reported in OSCC and OPMD. Specific objectives were to select a salivary biomarker panel suitable for early detection of OSCC and OPMD and to assess relationships between salivary biomarkers and risk factors. Methods: A literature search was conducted in academic databases (Scopus, Medline, Embase and Web of Science) without any restrictions. Following calibration, two blinded reviewers screened the studies and extracted data. A risk of bias assessment was conducted using Newcastle Ottawa scale. 295 studies were included with descriptive data analysis. Expert opinion: A salivary biomarker panel including Interleukin 1β, IL6 and IL8 was selected for OSCC and OPMD. Reported relationships between salivary biomarkers and risk factors are discussed and research gaps are highlighted. Future research should be directed to assess potential salivary biomarkers and their relationships to risk factors in order to understand the biomarker’s role in disease initiation.
- 12 July 2021
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 21 (8) , 789-807
Open AccessDiagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review
Introduction: Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) are a significant health burden globally. Smoking, alcohol and betel quid are the main risk factors. Lack of screening methods has been highlighted as a significant challenge in management. Salivary biomarkers are proposed as non-invasive diagnostic tools. The aim of this systematic review was to study salivary biomarkers reported in OSCC and OPMD. Specific objectives were to select a salivary biomarker panel suitable for early detection of OSCC and OPMD and to assess relationships between salivary biomarkers and risk factors. Methods: A literature search was conducted in academic databases (Scopus, Medline, Embase and Web of Science) without any restrictions. Following calibration, two blinded reviewers screened the studies and extracted data. A risk of bias assessment was conducted using Newcastle Ottawa scale. 295 studies were included with descriptive data analysis. Expert opinion: A salivary biomarker panel including Interleukin 1β, IL6 and IL8 was selected for OSCC and OPMD. Reported relationships between salivary biomarkers and risk factors are discussed and research gaps are highlighted. Future research should be directed to assess potential salivary biomarkers and their relationships to risk factors in order to understand the biomarker’s role in disease initiation.
- 1 December 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (12) , E349-E350
Organized Inpatient (Stroke Unit) Care for Stroke
- 1 December 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (12) , E349-E350
Organized Inpatient (Stroke Unit) Care for Stroke